173 related articles for article (PubMed ID: 4330931)
1. Effect of norgestrel in combination with ethinyl oestradiol on the human pituitary-adrenal axis.
Givens JR; Fort AT; Leigh JH
J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:69-76. PubMed ID: 4330931
[No Abstract] [Full Text] [Related]
2. Clinical use of norgestrel-ethinyl oestradiol as a contraceptive.
Tyler ET; Matsner EM; Gotlib MH; Levin M; Daniels T; Shimabukuro B; Dolman H; Elliot J
J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:109-16. PubMed ID: 5288229
[No Abstract] [Full Text] [Related]
3. Fertility control with Ovral. A clinical review.
Laurie RE; Lewis ET
J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:95-107. PubMed ID: 4256548
[No Abstract] [Full Text] [Related]
4. The effects of oral contraceptives on glucose tolerance.
Boshell BR; Roddam RF; McAdams GL; Fox OJ
J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:77-88. PubMed ID: 5288232
[No Abstract] [Full Text] [Related]
5. Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans.
Gerhards E; Lachnit U; Gaude R; Schillinger E
Arzneimittelforschung; 1973 Jun; 23(6):779-84. PubMed ID: 4740760
[No Abstract] [Full Text] [Related]
6. [Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles].
Lévrier M
Bord Med; 1970 Jan; 3(1):225-6. PubMed ID: 4948561
[No Abstract] [Full Text] [Related]
7. Serum triglyceride in women with and without a predisposition to diabetes during short-term administration of a combined oral contraception.
Nelson FH
Acta Obstet Gynecol Scand; 1974; 53(1):13-9. PubMed ID: 4817622
[No Abstract] [Full Text] [Related]
8. [Clinical studies on the stimulation and suppression of the pituitary-adrenocortical system. II. Studies on the pituitary-adrenocortical suppression test].
Sako T
Nihon Naibunpi Gakkai Zasshi; 1968 Dec; 44(9):1016-24. PubMed ID: 4304528
[No Abstract] [Full Text] [Related]
9. [Advances in hormonal contraception. A new micro-pll with especially low hormone effect].
Gynakologe; 1994 Apr; 27(2 Suppl):1-12. PubMed ID: 9131064
[No Abstract] [Full Text] [Related]
10. Effect of Ovral, a combination type oral contraceptive agent, on vitamin A metabolism in rats.
Supopark W; Olson JA
Int J Vitam Nutr Res; 1975; 45(2):113-23. PubMed ID: 1165158
[TBL] [Abstract][Full Text] [Related]
11. [Clinical trials of an association of norgestrel and ethinyl estradiol commercialized under the name of Stediril].
Gaudefroy M; Corette L; Coliche D
Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(4):434. PubMed ID: 5153231
[No Abstract] [Full Text] [Related]
12. Endometrial effects of Ovral.
Roland M
J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:89-93. PubMed ID: 5288233
[No Abstract] [Full Text] [Related]
13. Observations with Ovidon.
Farkas M; Falkay G; Szigethy A
Ther Hung; 1977; 25(3):93-101. PubMed ID: 929481
[No Abstract] [Full Text] [Related]
14. Effect of an oral contraceptive on serum phosphohexose isomerase activity.
Gupta U; Khuteta KP; Gupta RC
Indian J Physiol Pharmacol; 1983; 27(3):253-4. PubMed ID: 6668056
[No Abstract] [Full Text] [Related]
15. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
Zellner P; Klinger G
Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
[No Abstract] [Full Text] [Related]
16. Clinical observations with Rigevidon.
Bálint S
Ther Hung; 1980; 28(2):75-8. PubMed ID: 7466718
[TBL] [Abstract][Full Text] [Related]
17. Low-oestrogen combined oral contraceptive.
Foss GL; Fotherby K
Acta Eur Fertil; 1973 Jun; 4(2):57-8. PubMed ID: 4784140
[No Abstract] [Full Text] [Related]
18. Interrelationships between maternal and fetal pituitary-adrenal axis.
Kićović P; Subotić Z; Popović D
Acta Med Iugosl; 1970; 24(4):349-55. PubMed ID: 4325595
[No Abstract] [Full Text] [Related]
19. Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo.
Cullberg J
Acta Psychiatr Scand Suppl; 1972; 236():1-86. PubMed ID: 4565340
[No Abstract] [Full Text] [Related]
20. The impaired response to metyrapone in patients taking oestrogen.
Sprunt JG; Rutherford ER; Nelson DH
Acta Endocrinol (Copenh); 1968 Nov; 59(3):447-53. PubMed ID: 4301815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
